These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 33218096)

  • 21. Levels of serum-circulating angiogenic factors within 1 week prior to delivery are closely related to conditions of pregnant women with pre-eclampsia, gestational hypertension, and/or fetal growth restriction.
    Nanjo S; Minami S; Mizoguchi M; Yamamoto M; Yahata T; Toujima S; Shiro M; Kobayashi A; Muragaki Y; Ino K
    J Obstet Gynaecol Res; 2017 Dec; 43(12):1805-1814. PubMed ID: 28929598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of immunity in the pathogenesis and development of pre-eclampsia.
    Lu HQ; Hu R
    Scand J Immunol; 2019 Nov; 90(5):e12756. PubMed ID: 30739345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The correlation between cerebral MRI characteristics of posterior reversible encephalopathy syndrome and serum levels of PlGF, sEng in patients with pre-eclampsia].
    Jiang KM; Zhong X; Tan Y; Liu GC; Mai H; Wu SX
    Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):840-844. PubMed ID: 27916068
    [No Abstract]   [Full Text] [Related]  

  • 24. A balancing act: mechanisms by which the fetus avoids rejection by the maternal immune system.
    Warning JC; McCracken SA; Morris JM
    Reproduction; 2011 Jun; 141(6):715-24. PubMed ID: 21389077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Use of Soluble FMS-like Tyrosine Kinase 1/Placental Growth Factor Ratio in the Clinical Management of Pre-eclampsia.
    Govender N; Moodley J; Naicker T
    Afr J Reprod Health; 2018 Dec; 22(4):135-143. PubMed ID: 30632730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies.
    Helske S; Vuorela P; Carpén O; Hornig C; Weich H; Halmesmäki E
    Mol Hum Reprod; 2001 Feb; 7(2):205-10. PubMed ID: 11160848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Placental growth factor and pre-eclampsia.
    Chau K; Hennessy A; Makris A
    J Hum Hypertens; 2017 Dec; 31(12):782-786. PubMed ID: 29115294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human placenta-derived stromal cells decrease inflammation, placental injury and blood pressure in hypertensive pregnant mice.
    Chatterjee P; Chiasson VL; Pinzur L; Raveh S; Abraham E; Jones KA; Bounds KR; Ofir R; Flaishon L; Chajut A; Mitchell BM
    Clin Sci (Lond); 2016 Apr; 130(7):513-23. PubMed ID: 26685104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural killer cells and T lymphocytes in pregnancy and pre-eclampsia.
    Taylor EB; Sasser JM
    Clin Sci (Lond); 2017 Dec; 131(24):2911-2917. PubMed ID: 29222389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced HIF2α expression during human trophoblast differentiation into syncytiotrophoblast suppresses transcription of placental growth factor.
    Fujii T; Nagamatsu T; Morita K; Schust DJ; Iriyama T; Komatsu A; Osuga Y; Fujii T
    Sci Rep; 2017 Sep; 7(1):12455. PubMed ID: 28963486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulatory T cells in embryo implantation and the immune response to pregnancy.
    Robertson SA; Care AS; Moldenhauer LM
    J Clin Invest; 2018 Oct; 128(10):4224-4235. PubMed ID: 30272581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia.
    Turpin CA; Sakyi SA; Owiredu WK; Ephraim RK; Anto EO
    BMC Pregnancy Childbirth; 2015 Aug; 15():189. PubMed ID: 26303772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. XIAP protein is induced by placenta growth factor (PLGF) and decreased during preeclampsia in trophoblast cells.
    Arroyo J; Price M; Straszewski-Chavez S; Torry RJ; Mor G; Torry DS
    Syst Biol Reprod Med; 2014 Oct; 60(5):263-73. PubMed ID: 25003840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T lymphocytes and preeclampsia: The potential role of T-cell subsets and related MicroRNAs in the pathogenesis of preeclampsia.
    Zolfaghari MA; Arefnezhad R; Parhizkar F; Hejazi MS; Motavalli Khiavi F; Mahmoodpoor A; Yousefi M
    Am J Reprod Immunol; 2021 Nov; 86(5):e13475. PubMed ID: 34043850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Placental Galectins Are Key Players in Regulating the Maternal Adaptive Immune Response.
    Balogh A; Toth E; Romero R; Parej K; Csala D; Szenasi NL; Hajdu I; Juhasz K; Kovacs AF; Meiri H; Hupuczi P; Tarca AL; Hassan SS; Erez O; Zavodszky P; Matko J; Papp Z; Rossi SW; Hahn S; Pallinger E; Than NG
    Front Immunol; 2019; 10():1240. PubMed ID: 31275299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo evidence of significant placental growth factor release by normal pregnancy placentas.
    Cerdeira AS; Kandzija N; Pargmae P; Tome M; Zhang W; Cooke WR; Agrawal S; James T; Redman C; Vatish M
    Sci Rep; 2020 Jan; 10(1):132. PubMed ID: 31924819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
    Romero R; Nien JK; Espinoza J; Todem D; Fu W; Chung H; Kusanovic JP; Gotsch F; Erez O; Mazaki-Tovi S; Gomez R; Edwin S; Chaiworapongsa T; Levine RJ; Karumanchi SA
    J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial.
    Duhig KE; Myers J; Seed PT; Sparkes J; Lowe J; Hunter RM; Shennan AH; Chappell LC;
    Lancet; 2019 May; 393(10183):1807-1818. PubMed ID: 30948284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia--a step forward but not the definitive answer.
    Foidart JM; Schaaps JP; Chantraine F; Munaut C; Lorquet S
    J Reprod Immunol; 2009 Nov; 82(2):106-11. PubMed ID: 19853925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The placenta in toxicology. Part II: Systemic and local immune adaptations in pregnancy.
    Svensson-Arvelund J; Ernerudh J; Buse E; Cline JM; Haeger JD; Dixon D; Markert UR; Pfarrer C; De Vos P; Faas MM
    Toxicol Pathol; 2014; 42(2):327-38. PubMed ID: 23531796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.